Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Return to Play for Athletes After COVID-19 Infection

Return to Play for Athletes After COVID-19 Infection Opinion EDITORIAL The Fog Begins to Clear James E. Udelson, MD; Ethan J. Rowin, MD; Barry J. Maron, MD In October 2020, Kim and colleagues, representing the Ameri- normal ECG, echocardiography, and troponin test results, who can College of Cardiology’s Sports and Exercise Council, would not have been identified without CMR imaging. While some of the prior studies involving smaller patient cohorts had published recommendations for the evaluation of athletes 2,4,5 who had tested positive for also reported all athletes undergoing CMR imaging, it was COVID-19 to ensure safe re- unclear what selection may have taken place before CMR Related article page 1078 turn to play. The group rec- imaging referral. ommended a tiered approach This mandated comprehensive testing in a large group of based on the presence of symptoms, followed by electrocar- collegiate athletes provides the novel opportunity not previ- diography (ECG), injury biomarkers, and echocardiography. ously available in large athlete cohorts (to our knowledge) to Abnormalities were then to be further characterized by the se- construct the data in their Figure 2, which succinctly sum- lective use of cardiac magnetic resonance (CMR) imaging. The marizes what would have been detected and missed by vari- recommendations were based http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Cardiology American Medical Association

Return to Play for Athletes After COVID-19 Infection

Loading next page...
 
/lp/american-medical-association/return-to-play-for-athletes-after-covid-19-infection-YgryOd1cgL

References (18)

Publisher
American Medical Association
Copyright
Copyright 2021 American Medical Association. All Rights Reserved.
ISSN
2380-6583
eISSN
2380-6591
DOI
10.1001/jamacardio.2021.2079
Publisher site
See Article on Publisher Site

Abstract

Opinion EDITORIAL The Fog Begins to Clear James E. Udelson, MD; Ethan J. Rowin, MD; Barry J. Maron, MD In October 2020, Kim and colleagues, representing the Ameri- normal ECG, echocardiography, and troponin test results, who can College of Cardiology’s Sports and Exercise Council, would not have been identified without CMR imaging. While some of the prior studies involving smaller patient cohorts had published recommendations for the evaluation of athletes 2,4,5 who had tested positive for also reported all athletes undergoing CMR imaging, it was COVID-19 to ensure safe re- unclear what selection may have taken place before CMR Related article page 1078 turn to play. The group rec- imaging referral. ommended a tiered approach This mandated comprehensive testing in a large group of based on the presence of symptoms, followed by electrocar- collegiate athletes provides the novel opportunity not previ- diography (ECG), injury biomarkers, and echocardiography. ously available in large athlete cohorts (to our knowledge) to Abnormalities were then to be further characterized by the se- construct the data in their Figure 2, which succinctly sum- lective use of cardiac magnetic resonance (CMR) imaging. The marizes what would have been detected and missed by vari- recommendations were based

Journal

JAMA CardiologyAmerican Medical Association

Published: Sep 27, 2021

There are no references for this article.